Literature DB >> 14985920

The sigma1 (sigma1) receptor activation is a key step for the reactivation of cocaine conditioned place preference by drug priming.

Pascal Romieu1, Johann Meunier, Déborah Garcia, Nadia Zozime, Rémi Martin-Fardon, Wayne D Bowen, Tangui Maurice.   

Abstract

RATIONALE: Cocaine-seeking behavior can be investigated in rodents using the conditioned place preference (CPP) paradigm, in which the drug-paired environment serves as a conditioned stimulus. Such approach allowed to previously demonstrate the importance of the neuromodulatory sigma1 (sigma1) receptor in acquisition of cocaine-induced CPP. CPP can be extinguished and then reactivated, notably using a cocaine challenge (i.e., priming). OBJECTIVES AND METHODS: In order to examine the role of the sigma1 receptor in reinstatement of Cocaine-seeking, Swiss mice acquired CPP with cocaine (30 mg/kg, i.p.) and then CPP was extinguished.
RESULTS: A challenge cocaine priming (15 mg/kg) reactivated CPP up to 140% of the post-conditioning response. Pre-administration of the sigma1 receptor antagonist BD1047 (330 mg/kg, i.p.) or repeated treatment with an antisense probe targeting the sigma1 receptor prevented CPP reactivation. The sigma1 agonist igmesine (1-10 mg/kg, i.p.) or the steroid dehydroepiandrosterone (DHEA, 10-40 mg/kg, s.c.) reactivated CPP, in a BD1047-sensitive manner. Moreover, the in vivo [3H](+)-SKF-10,047 binding levels to the sigma1 receptor were increased after cocaine conditioning in numerous brain structures and these increases subsisted after extinction. Finally, cross-reactivation of cocaine-induced CPP was observed after phencyclidine (PCP), morphine, nicotine and ethanol administration. However, BD1047 blocked reactivation of CPP induced by PCP, morphine and nicotine but not ethanol.
CONCLUSIONS: Since activation of the sigma1 receptor is not sufficient to sustain CPP in naive animals [Neuropsychopharmacology 26 (2002) 444], it is concluded that sigma1 receptor activation is a key event for relapse to drug seeking. Activation may occur via sensitization due to enhanced in vivo available of receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985920     DOI: 10.1007/s00213-004-1814-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  40 in total

Review 1.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

2.  Cocaine-induced conditioned place preference in mice: induction, extinction and reinstatement by related psychostimulants.

Authors:  Yossef Itzhak; Julio L Martin
Journal:  Neuropsychopharmacology       Date:  2002-01       Impact factor: 7.853

3.  Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction.

Authors:  D Mueller; J Stewart
Journal:  Behav Brain Res       Date:  2000-10       Impact factor: 3.332

4.  Conditioning factors in drug abuse: can they explain compulsion?

Authors:  C P O'Brien; A R Childress; R Ehrman; S J Robbins
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

5.  Enduring resistance to extinction of cocaine-seeking behavior induced by drug-related cues.

Authors:  F Weiss; R Martin-Fardon; R Ciccocioppo; T M Kerr; D L Smith; O Ben-Shahar
Journal:  Neuropsychopharmacology       Date:  2001-09       Impact factor: 7.853

6.  Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference.

Authors:  P Romieu; R Martin-Fardon; T Maurice
Journal:  Neuroreport       Date:  2000-09-11       Impact factor: 1.837

Review 7.  Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity.

Authors:  Tangui Maurice; Rémi Martin-Fardon; Pascal Romieu; Rae R Matsumoto
Journal:  Neurosci Biobehav Rev       Date:  2002-06       Impact factor: 8.989

8.  N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice.

Authors:  R R Matsumoto; K A McCracken; B Pouw; J Miller; W D Bowen; W Williams; B R De Costa
Journal:  Eur J Pharmacol       Date:  2001-01-12       Impact factor: 4.432

9.  Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors.

Authors:  R Bergeron; C de Montigny; G Debonnel
Journal:  J Neurosci       Date:  1996-02-01       Impact factor: 6.167

10.  Cocaine-induced cocaine craving.

Authors:  J H Jaffe; N G Cascella; K M Kumor; M A Sherer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

View more
  34 in total

1.  Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine.

Authors:  Rae R Matsumoto; Su-Min Li; Jonathan L Katz; William E Fantegrossi; Andrew Coop
Journal:  Drug Alcohol Depend       Date:  2011-03-21       Impact factor: 4.492

2.  The effect of the pyridyl nitrogen position in pyridylpiperazine sigma ligands.

Authors:  Lidiya Stavitskaya; Michael J Seminerio; Marilyn M Matthews-Tsourounis; Rae R Matsumoto; Andrew Coop
Journal:  Bioorg Med Chem Lett       Date:  2010-03-01       Impact factor: 2.823

Review 3.  Modeling relapse in animals.

Authors:  Rémi Martin-Fardon; Friedbert Weiss
Journal:  Curr Top Behav Neurosci       Date:  2013

4.  Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine.

Authors:  Yuko Yasui; Tsung-Ping Su
Journal:  J Drug Alcohol Res       Date:  2016-02-20

5.  Extinction of morphine-dependent conditioned behavior is associated with increased phosphorylation of the GluR1 subunit of AMPA receptors at hippocampal synapses.

Authors:  Sophie K Billa; Namita Sinha; Sri Rajyalakshmi Rudrabhatla; Jose A Morón
Journal:  Eur J Neurosci       Date:  2008-12-11       Impact factor: 3.386

6.  Interactions between 3,4-methylenedioxymethamphetamine and sigma1 receptors.

Authors:  Matthew K Brammer; Deborah L Gilmore; Rae R Matsumoto
Journal:  Eur J Pharmacol       Date:  2006-09-28       Impact factor: 4.432

7.  Selective reduction of alcohol drinking in Sardinian alcohol-preferring rats by a sigma-1 receptor antagonist.

Authors:  Valentina Sabino; Pietro Cottone; Yu Zhao; Luca Steardo; George F Koob; Eric P Zorrilla
Journal:  Psychopharmacology (Berl)       Date:  2009-05-14       Impact factor: 4.530

8.  The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.

Authors:  Melanie A Paquette; Katherine Foley; Elizabeth G Brudney; Charles K Meshul; Steven W Johnson; S Paul Berger
Journal:  Psychopharmacology (Berl)       Date:  2009-03-13       Impact factor: 4.530

Review 9.  The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking.

Authors:  Sunila G Nair; Tristan Adams-Deutsch; David H Epstein; Yavin Shaham
Journal:  Prog Neurobiol       Date:  2009-06-02       Impact factor: 11.685

10.  Pharmacology and therapeutic potential of sigma(1) receptor ligands.

Authors:  E J Cobos; J M Entrena; F R Nieto; C M Cendán; E Del Pozo
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.